← Leaderboards
Donna C Porter
Replicon Technologies, Inc.
$791,537
Attributed
$791,537
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$791,537 · 2
By mechanism
R44$765,637 · 1
R13$25,900 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Scid Mouse”
- Ann M Arvin · Stanford University$12,530,940
- Jordan S Pober · Yale University$11,234,880
- Jacques Eduardo Nor · University Of Michigan At Ann Arbor$10,041,288
- Madhavan P Nair · State University Of New York At Buffalo$9,783,132
- Howard Eliot Gendelman · Children'S Memorial Hospital (Chicago)$9,406,374
- Jerome A. Zack · University Of California Los Angeles$8,722,372
Research focus
Scid MouseNonhuman Therapy EvaluationRepliconSouthern BlottingNeoplasm /Cancer GeneticsGliomaNeoplasm /Cancer TherapyPolymerase Chain ReactionTransfection /Expression VectorGene TherapyPoliovirusCollaborationsAreaCommunitiesCaringCareer DevelopmentAppointmentAcquired Immunodeficiency SyndromeFundingBiologicalFosteringGenderFeedbackBehavioral/Social Science
Grant awards (4)
Inter-CFAR (Center for AIDS Research) Collaborative Symposium on HIV Research in Women$25,900
R13 · FY2016 · AI · contact PI
Development of Replicons as Brain Tumor Therapies$471,894
R44 · FY2003 · CA
Development of Replicons as Brain Tumor Therapies$224,703
R44 · FY2002 · CA
Development of Replicons as Brain Tumor Therapies$69,040
R44 · FY2001 · CA